慢性阻塞性肺病中的粘液过分分泌及其治疗方法
Binay Kumar Shah1,2, Bivek Singh2, Yukun Wang2
1Department of Respiratory Medicine, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China.
慢性阻塞性肺病 (COPD) 中的慢性粘液过分分泌 (CMH) 会增加健康风险. 本综述探讨了粘液结构,CMH影响和治疗方法,以管理COPD患者的呼吸道粘液.
科学领域:
- 肺部医学 肺部医学
- 细胞生物学 细胞生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性阻塞性肺病 (COPD) 通常涉及气道粘液过分分泌,这是患者发病率和死亡率的关键因素.
- 呼吸道粘液对肺部防御至关重要,它可以捕获病原体和颗粒物,以便清除.
- 慢性粘液高分泌 (CMH) 在某些COPD患者群体中显著增加风险.
研究的目的:
- 审查肺粘液的结构和功能,特别是形成凝的粘膜.
- 讨论CMH在COPD中的病理影响.
- 总结当前和新的治疗策略来管理COPD中的CMH.
主要方法:
- 文献审查侧重于粘液结构,CMH和COPD.
- 对现有的药物和非药物治疗方法的分析.
- 探索CMH控制的干预程序.
主要成果:
- 凝形成的粘膜是粘液结构和功能的核心.
- CMH会加剧COPD的进展和相关并发症.
- 一系列的治疗方法,从药物到干预措施,可以帮助管理CMH.
结论:
- 了解粘液生理学和CMH病理生理学对于COPD管理至关重要.
- 有效控制CMH对于改善COPD患者的治疗结果至关重要.
- 需要对新型治疗方法进行进一步的研究,以加强CMH管理策略.
更多相关视频
03:25Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
Published on: December 27, 2024
09:24Mucin Agarose Gel Electrophoresis: Western Blotting for High-molecular-weight Glycoproteins
Published on: June 14, 2016
相关概念视频
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Cystic Fibrosis: Management
Sinus disease and chronic...
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
